Bottom line
Is AZTD a good fund? The bottom line
AZTD is a managed global stock ETF from Franklin Templeton.
Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 74% of global stock funds we track.
It returned +7.0% over one year (as of Dec 31, 2024, per its prospectus).
With $37.9 million in net assets and 50 holdings, its largest position is DaVita Inc (3.1%) and the top 10 make up 25.9% of the portfolio.
What to watch
- Small fund ($37.9 million) — small funds are likelier to close
- High turnover (316% a year) can mean more taxable distributions
Updated Nov 19, 2026
What AZTD invests in
The Aztlan Global Stock Selection DM SMID ETF (the Fund) seeks to track the performance, before fees and expenses, of the Solactive Aztlan Global Developed Markets SMID Cap Index (the Index, or the Global Index).
The Fund uses a passive management (or indexing) approach to track the performance, before fees and expenses, of the Index. The Index is based on a proprietary methodology created by Aztlan Equity Management, LLC (Aztlan) that follows a non-discretionary, rules-based methodology to determine the universe of potential Index components. The Index is owned, calculated, administered, and published by Solactive AG (Solactive). Solactive Aztlan Global Developed Markets SMID Cap Index The Index is comprised of equity securities of companies from the following three developed markets (DM) regions: North America (United States and Canada), Western Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom), and Asia (Australia, Japan and New Zealand, but excluding Hong Kong and Singapore).…
From the fund's prospectus (filed Nov 24, 2025).
AZTD performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| AZTD | +7.0% | — | — |
| Global Stock median | +15.2% | +7.6% | +9.5% |
Source: Fund prospectus, as of Dec 31, 2024
What AZTD costs
On a $10,000 investment, AZTD's 0.75% expense ratio costs about $75 a year. The prospectus estimates $930 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.
AZTD top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | DaVita Inc DVA | 3.06% |
| 2 | Enova International Inc ENVA | 2.96% |
| 3 | Medpace Holdings Inc MEDP | 2.90% |
| 4 | Cybozu Inc 4776 | 2.51% |
| 5 | Happinet Corp 7552 | 2.45% |
| 6 | Halozyme Therapeutics Inc HALO | 2.45% |
| 7 | Virtu Financial Inc VIRT | 2.40% |
| 8 | Docusign Inc DOCU | 2.40% |
| 9 | Food & Life Cos Ltd 3563 | 2.40% |
| 10 | Sterling Infrastructure Inc STRL | 2.38% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 25.9% of the fund. See all top 25 holdings and asset mix →